+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

South and Central America RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Molecule Type, Application, Route of Administration, and End User; and Country

  • PDF Icon

    Report

  • 114 Pages
  • December 2020
  • The Insight Partners
  • ID: 5236369
UP TO OFF until Jun 30th 2024
According to our new market research study on “South & Central America RNAi Therapeutics Market to 2027 - Regional Analysis and Forecast - by Molecule Type, Route of Administration, Application, and End User,” the South & Central America RNAi therapeutics market is expected to reach US$ 38.70 million by 2027 from US$ 21.22 million in 2019, it is estimated to grow at a CAGR of 7.9% from 2020 to 2027. The report provides trends prevailing in the South & Central America RNAi therapeutics market and the factors driving the market growth along with those hindering it.

In 2019, the small interfering RNAs (siRNA) segment accounted for higher share of the market. Growth of this segment is attributed to increasing preference for small interfering RNAs for drug development and growing number of research partnerships. The microRNA (miRNA) segment is expected to register higher CAGR in the RNAi therapeutics market during the forecast period.

The growth of the South & Central America RNAi therapeutics market is mainly attributed to growing prevalence of chronic conditions and rising investments for development of RNAi therapeutics. Additionally, increasing awareness about RNAi therapies and their benefits are anticipated to boost the research and innovations of RNAi therapeutics in the region, which would eventually drive the market growth. However, the high cost of RNAi therapy development is the major factor hindering the market growth in South & Central America.

Quark; Rexahn Pharmaceuticals, Inc; Arbutus Biopharma; Alnylam Pharmaceuticals, Inc; and Arrowhead Pharmaceuticals, Inc are among the leading companies operating in the South & Central America RNAi therapeutics market.

The report segments the South & Central America RNAi therapeutics market as follows:

South & Central America RNAi Therapeutics Market - by Molecule Type
  • Small Interfering RNAs (siRNA)
  • MicroRNA (miRNA)

South & Central America RNAi Therapeutics Market - by Route of Administration
  • Pulmonary Delivery
  • Intravenous Injections
  • Intradermal Injections
  • Intraperitoneal Injections
  • Others

South & Central America RNAi Therapeutics Market - by Application
  • Oncology
  • Cardiovascular
  • Respiratory Disorders
  • Renal Diseases
  • Genetic Disorders
  • Neurodegenerative Disorders
  • Infectious Diseases
  • Others

South & Central America RNAi Therapeutics Market - by End User
  • Research and Academic Laboratories
  • Hospitals
  • Diagnostic Laboratories

South & Central America RNAi Therapeutics Market - by Country
  • South & Central America
  • Brazil
  • Argentina
  • Rest of South Central & America

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM braking resistors market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the SAM braking resistors market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging market.
  • Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the braking resistors market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Closed system drug transfer devices Market - By Closing Mechanism
1.3.2 South & Central America Closed system drug transfer devices Market - By Type
1.3.3 South & Central America Closed system drug transfer devices Market- By Technology
1.3.4 South & Central America Closed system drug transfer devices Market- By Component
1.3.5 South & Central America Closed system drug transfer devices Market- By End User
1.3.6 South & Central America Closed system drug transfer devices Market - By Country
2. South & Central America Closed System Drug Transfer Devices Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Closed System Drug Transfer Devices Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Closed System Drug Transfer Devices Market - South & Central America PEST Analysis
4.3 Expert Opinion
4.4 Regulatory Overview
4.5 Value Chain Analysis
5. South & Central America Closed System Drug Transfer Devices Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Adoption of Chemotherapy
5.1.2 Improvement of Regulatory Guidelines Regarding Hazardous Drugs
5.2 Market Restraints
5.2.1 Lack of Regulatory Guidelines Regarding Health Workers’ Safety
5.3 Market Opportunities
5.3.1 Rising Number of Chemotherapeutic Drug Approvals
5.4 Future Trends
5.4.1 Robot-based Handling of Hazardous Drugs
5.5 Impact analysis
6. Closed System Drug Transfer Devices Market - South & Central America Analysis
6.1 South & Central America Closed System Drug Transfer Devices Market Revenue Forecasts and Analysis
7. South & Central America Closed System Drug Transfer Devices Market Analysis and Forecasts To 2027 - By Closing Mechanism
7.1 Overview
7.2 South & Central America Closed System Drug Transfer Devices Market, By Closing Mechanism 2019 & 2027 (%)
7.2.1 South & Central America Closed System Drug Transfer Devices Market Revenue and Forecasts to 2027, By Closing Mechanism (US$ Mn)
7.3 Push-to-Turn Systems
7.3.1 Overview
7.3.2 South & Central America Push-to-Turn Systems Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Colour-to-Colour Alignment System
7.4.1 Overview
7.4.2 South & Central America Colour-to-Colour Alignment System Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Luer-Lock Systems
7.5.1 Overview
7.5.2 South & Central America Luer-Lock Systems Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Click-to-Lock Systems
7.6.1 Overview
7.6.2 South & Central America Click-to-Lock Systems Market Revenue and Forecast to 2027 (US$ Mn)
8. South & Central America Closed System Drug Transfer Devices Market Analysis and Forecasts To 2027 - By Type
8.1 Overview
8.2 South & Central America Closed System Drug Transfer Devices Market, By Type 2019 & 2027 (%)
8.2.1 South & Central America Closed System Drug Transfer Devices Market Revenue and Forecasts to 2027, By Type (US$ Mn)
8.3 Membrane-to-Membrane Systems
8.3.1 Overview
8.3.2 South & Central America Membrane-to-Membrane Systems Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Needleless Systems
8.4.1 Overview
8.4.2 South & Central America Needleless Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9. South & Central America Closed System Drug Transfer Devices Market Analysis and Forecasts To 2027 - By Technology
9.1 Overview
9.2 South & Central America Closed System Drug Transfer Devices Market, By Technology 2019 & 2027 (%)
9.2.1 South & Central America Closed System Drug Transfer Devices Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
9.3 Diaphragm-Based Devices
9.3.1 Overview
9.3.2 South & Central America Diaphragm-Based Devices Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Compartmentalized Devices
9.4.1 Overview
9.4.2 South & Central America Compartmentalized Devices Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Air Cleaning/Filtration Devices
9.5.1 Overview
9.5.2 South & Central America Air Cleaning/Filtration Devices Market Revenue and Forecast to 2027 (US$ Mn)
10. South & Central America Closed System Drug Transfer Devices Market Analysis and Forecasts To 2027 - By Component
10.1 Overview
10.2 South & Central America Closed System Drug Transfer Devices Market, By Component 2019 & 2027 (%)
10.2.1 South & Central America Closed System Drug Transfer Devices Market Revenue and Forecasts to 2027, By Component (US$ Mn)
10.3 Vial Access Devices
10.3.1 Overview
10.3.2 South & Central America Vial Access Devices Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Syringe Safety Devices
10.4.1 Overview
10.4.2 South & Central America Syringe Safety Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Bag/Line Access Devices
10.5.1 Overview
10.5.2 South & Central America Bag/Line Access Devices Market Revenue and Forecast to 2027 (US$ Mn)
10.6 Accessories
10.6.1 Overview
10.6.2 South & Central America Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
11. South & Central America Closed System Drug Transfer Devices Market Analysis - By End-User
11.1 Overview
11.2 South & Central America Closed System Drug Transfer Devices Market, By End-User 2019-2027 (%)
11.2.1 South & Central America Closed System Drug Transfer Devices Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
11.3 Hospitals and Clinics
11.3.1 Overview
11.3.2 South & Central America Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
11.4 Oncology Centers
11.4.1 Overview
11.4.2 South & Central America Oncology Centers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5 Others
11.5.1 Overview
11.5.2 South & Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)
12. Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027 - Geographical Analysis
12.1 South & Central America: Closed System Drug Transfer Devices Market
12.1.1 Overview
12.1.2 South and Central America: Closed System Drug Transfer Device (CSTD) Market - Revenue and Forecast to 2027 (USD Million)
12.1.3 South and Central America Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism - Revenue and Forecast to 2027 (USD Million)
12.1.4 South and Central America Closed System Drug Transfer Device (CSTD) Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.5 South and Central America Closed System Drug Transfer Device (CSTD) Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.6 South and Central America Closed System Drug Transfer Device (CSTD) Market, by Component - Revenue and Forecast to 2027 (USD Million)
12.1.7 South and Central America Closed System Drug Transfer Device (CSTD) Market, by End-User - Revenue and Forecast to 2027 (USD Million)
12.1.8 South and Central America: Closed System Drug Transfer Device (CSTD) Market, by Country, 2019 & 2027 (%)
12.1.9 Brazil: Closed System Drug Transfer Device (CSTD) Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.1 Brazil: Closed System Drug Transfer Device (CSTD) Market - Revenue and Forecast to 2027 (USD Million)
12.1.10 Brazil Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism - Revenue and Forecast to 2027 (USD Million)
12.1.11 Brazil Closed System Drug Transfer Device (CSTD) Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.12 Brazil Closed System Drug Transfer Device (CSTD) Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.13 Brazil Closed System Drug Transfer Device (CSTD) Market, by Component - Revenue and Forecast to 2027 (USD Million)
12.1.14 Brazil Closed System Drug Transfer Device (CSTD) Market, by End-User - Revenue and Forecast to 2027 (USD Million)
12.1.15 Argentina: Closed System Drug Transfer Device (CSTD) Market - Revenue and Forecast to 2027 (USD Million)
12.1.15.1 Argentina: Closed System Drug Transfer Device (CSTD) Market - Revenue and Forecast to 2027 (USD Million)
12.1.16 Argentina Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism - Revenue and Forecast to 2027 (USD Million)
12.1.17 Argentina Closed System Drug Transfer Device (CSTD) Market, by Type - Revenue and Forecast to 2027 (USD Million)
12.1.18 Argentina Closed System Drug Transfer Device (CSTD) Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.19 Argentina Closed System Drug Transfer Device (CSTD) Market, by Component - Revenue and Forecast to 2027 (USD Million)
12.1.20 Argentina Closed System Drug Transfer Device (CSTD) Market, by End-User - Revenue and Forecast to 2027 (USD Million)
13. Impact of COVID-19 Pandemic on South & Central America Closed system drug transfer devices Market
13.1 South & Central America: Impact Assessment of COVID-19 Pandemic
14. Company Profiles
14.1 BD
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 B. Braun Medical Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 ICU MEDICAL INC.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 EQUASHIELD
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Victus, Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
List of Tables
Table 1. South & Central America Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027, By Closing Mechanism (US$ Mn)
Table 2. South & Central America Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 3. South & Central America Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027, By Technology (US$ Mn)
Table 4. South & Central America Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027, By Component (US$ Mn)
Table 5. South & Central America Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 6. South and Central America Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism - Revenue and Forecast to 2027 (USD Million)
Table 7. South and Central America Closed System Drug Transfer Device (CSTD) Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 8. South and Central America Closed System Drug Transfer Device (CSTD) Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 9. South and Central America Closed System Drug Transfer Device (CSTD) Market, by Component - Revenue and Forecast to 2027 (USD Million)
Table 10. South and Central America Closed System Drug Transfer Device (CSTD) Market, by End-User - Revenue and Forecast to 2027 (USD Million)
Table 11. Brazil Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism - Revenue and Forecast to 2027 (USD Million)
Table 12. Brazil Closed System Drug Transfer Device (CSTD) Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 13. Brazil Closed System Drug Transfer Device (CSTD) Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 14. Brazil Closed System Drug Transfer Device (CSTD) Market, by Component - Revenue and Forecast to 2027 (USD Million)
Table 15. Brazil Closed System Drug Transfer Device (CSTD) Market, by End-User - Revenue and Forecast to 2027 (USD Million)
Table 16. Argentina Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism - Revenue and Forecast to 2027 (USD Million)
Table 17. Argentina Closed System Drug Transfer Device (CSTD) Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 18. Argentina Closed System Drug Transfer Device (CSTD) Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 19. Argentina Closed System Drug Transfer Device (CSTD) Market, by Component - Revenue and Forecast to 2027 (USD Million)
Table 20. Argentina Closed System Drug Transfer Device (CSTD) Market, by End-User - Revenue and Forecast to 2027 (USD Million)
Table 21. Glossary of Terms, Closed System Drug Transfer Devices Market
List of Figures
Figure 1. Closed System Drug Transfer Devices Market Segmentation
Figure 2. South & Central America Closed System Drug Transfer Devices Market Overview
Figure 3. Push-to-Turn Systems Closing Mechanism Segment Held Largest Share of Closed System Drug Transfer Devices Market
Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. South & Central America Closed system drug transfer devices Market - Leading Country Markets (US$ Mn)
Figure 6. Closed System Drug Transfer Devices Market - South & Central America PEST Analysis
Figure 7. Closed System Drug Transfer Devices Market - Value Chain Analysis
Figure 8. Closed System Drug Transfer Devices Market Impact Analysis of Driver and Restraints
Figure 9. South & Central America Closed System Drug Transfer Devices Market - Revenue Forecasts and Analysis - 2019- 2027
Figure 10. South & Central America Closed System Drug Transfer Devices Market, By Closing Mechanism 2019 & 2027 (%)
Figure 11. South & Central America Push-to-Turn Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. South & Central America Colour-to-Colour Alignment System Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. South & Central America Luer-Lock Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. South & Central America Click-to-Lock Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. South & Central America Closed System Drug Transfer Devices Market, By Type 2019 & 2027 (%)
Figure 16. South & Central America Membrane-to-Membrane Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. South & Central America Needleless Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. South & Central America Closed System Drug Transfer Devices Market, By Technology 2019 & 2027 (%)
Figure 19. South & Central America Diaphragm-Based Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. South & Central America Compartmentalized Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. South & Central America Air Cleaning/Filtration Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. South & Central America Closed System Drug Transfer Devices Market, By Component 2019 & 2027 (%)
Figure 23. South & Central America Vial Access Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. South & Central America Syringe Safety Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. South & Central America Bag/Line Access Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. South & Central America Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. South & Central America Closed System Drug Transfer Devices Market, by End-User 2019 & 2027 (%)
Figure 28. South & Central America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. South & Central America Oncology Centers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. South & Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. South and Central America: Closed System Drug Transfer Device (CSTD) Market, by Key Country - Revenue (2019) (USD Million)
Figure 32. South and Central America Closed System Drug Transfer Device (CSTD) Market Revenue and Forecast to 2027 (USD Million)
Figure 33. South and Central America: Closed System Drug Transfer Device (CSTD) Market, by Country, 2019 & 2027 (%)
Figure 34. Brazil: Closed System Drug Transfer Device (CSTD) Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. Argentina: Closed System Drug Transfer Device (CSTD) Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Impact of COVID-19 Pandemic in South & Central American Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • B. Braun Medical Inc
  • Victus, Inc
  • BD
  • EQUASHIELD
  • ICU MEDICAL INC.